Clinical Trial Update: A Study of Risperidone Monotherapy in Bipolar Anxiety [Phase 4]

View source ↗

Summary

Phase 4 trial of risperidone monotherapy for bipolar anxiety has completed, examining efficacy in bipolar disorder with co-occurring panic or generalized anxiet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Generalized Anxiety Disorder
• Panic Disorder

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: University of South Florida | Conditions: Bipolar Disorder, Panic Disorder | Phase 4 | Status: COMPLETED